2014

Celator(R) Pharmaceuticals Announces Pricing of a $12.9 Million Public …MarketWatchCelator Pharmaceuticals, Inc. CPXX, -4.33% a pharmaceutical company developing new and more effective therapies to treat cancer, today announced the pricing of an underwritten public offering of 6,611,150 shares of common stock and warrants to … and more …read more

Transgenomic Announces $2.375 Million Private Placement FinancingPharmiWeb.com (press release)For each share of common stock purchased investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and

Transgenomic Announces $2.375M Private Placement FinancingBenzingaFor each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and more …read more

Transgenomic Announces $2.375 Million Private Placement FinancingMarketWatchFor each share of common stock purchased, investors also received a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $4.00 per share. The warrants have a term of exercise equal to five years from the first date of … and more …read

Comstock Holds Initial Closing for Private Placement OfferingDigitalJournal.comIn connection with the private placement, the Company has agreed to issue warrants (“Warrants,” and each a “Warrant”) to purchase shares of the Company’s Class A Common Stock (the “Class A Common Stock”) to purchasers other than CDS who purchase … and more …read more